HLB Life Science Co., Ltd. (KOSDAQ:067630)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Medicare Division	28.02B	30.19B	35.79B	-	-
Medicare Division Growth	-7.19%	-15.64%	-	-	-
Other	5.86B	4.99B	5.17B	4.55B	4.04B
Other Growth	17.41%	-3.40%	13.68%	12.50%	5.01%
Construction and Engineering	1.01B	1.36B	5.89B	11.57B	14.32B
Construction and Engineering Growth	-26.04%	-76.86%	-49.15%	-19.18%	29.99%
Bio Development	788.51M	425.99M	312.98M	12.68M	7.28M
Bio Development Growth	85.10%	36.11%	2368.50%	74.07%	-96.53%
Pharmaceutical Distribution	69.47B	63.42B	54.06B	37.73B	75.06B
Pharmaceutical Distribution Growth	9.54%	17.31%	43.26%	-49.73%	-30.41%
Internal Sales	-2.90B	-2.39B	-1.62B	-372.94M	-1.63B
Total	102.24B	97.99B	99.59B	53.49B	91.80B
Total Growth	4.34%	-1.61%	86.17%	-41.73%	-19.49%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	100.88B	97.63B	99.48B	53.49B	91.80B
South Korea Growth	3.32%	-1.86%	85.97%	-41.73%	-19.49%
Foreign Country	1.36B	360.71M	107.14M	-	-
Foreign Country Growth	278.23%	236.66%	-	-	-
Total	102.24B	97.99B	99.59B	53.49B	91.80B
Total Growth	4.34%	-1.61%	86.17%	-41.73%	-19.49%

Source: S&P Global Market Intelligence.